Overview:
Oxidative stress is a result of an imbalance between reactive oxygen species and body’s ability to detoxify it. Such discrepancies in the redox state of the cell lead to the generation of peroxides and free radicals that may damage the cell components including lipids, proteins, and DNA. Oxidative stress assay is a method to evaluate the oxidative stress level of cells as sustained oxidative stress can lead to cancer, Parkinson's & Alzheimer’s disease, atherosclerosis and inflammatory diseases among others. The prime factors for the market growth include technological advancement in the oxidative stress assay equipment, prompt growth in the pharmaceutical and biotechnology companies, and rising government funding for the life science research in developed countries. Additionally, the rise in end-users for oxidative stress assay expected to catalyze the market growth. However, the cost of equipment and lack of public awareness & skilled professionals hinders the market growth during the forecast period.
The global oxidative stress assay market is segmented based on the test types, technologies, end-users, and geography. Based on the test types, the global market is segmented into antioxidant capacity assays, indirect assays, reactive oxygen species (ROS)-based assays, and enzyme-based assays. Based on the technologies, the market is segmented into chromatography, enzyme-linked immunosorbent assay (ELISA), microscopy, flow cytometry, label-free detection technology, and high-content screening. In 2017, the ELISA segment dominated the global market owing to the high adoption of the assays and better specificity and sensitivity. Based on the end-users, the global market is segmented into biotechnology and pharmaceutical companies, clinical laboratories, contract research organizations (CROs), and academic research institutes.
In 2017, North America dominated the global market followed by Europe. The supremacy of the regions is attributed to the technological advancements and availability of the advanced infrastructure. Furthermore, the rising geriatric pool fuels the market. According to the US Census Bureau, the population of the United States above 60 years of age expected to rise from 10.40% in 2015 to 12.55% in 2025. The Asia Pacific is identified as the fastest growing market due to rising healthcare infrastructure and favorable government initiatives.
The Global Oxidative Stress Assay Market is segmented on the following bases:
Key Players Identified in Oxidative Stress Assay Market include:
AMS Biotechnology, Abcam PLC, Merck and Co. Inc., BioVision Inc., Cell Biolabs Inc., Oxford Biomedical Research, Enzo Biochem, Sigma-Aldrich Corporation, QIAGEN N.V., Thermo Fisher Scientific, and Promega Corporation.
This report offers: